NeuroMetrix, Inc. announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction test for evaluation of peripheral neuropathies such as diabetic peripheral neuropathy (DPN). DPNCheck was launched in China in 2016 by Omron Medical (Beijing) Ltd., the Company’s exclusive China distributor. In addition to DPNCheck, Omron markets a wide range of medical products with a particular focus on diabetes and metabolic issues. Omron has been a leader in the establishment of comprehensive metabolic testing centers in hospitals with a large diabetes population. Currently there are over 300 China hospitals offering an Omron-designed Metabolic Management Center (MMC) which encompasses DPNCheck testing.